Current state of the polymeric delivery systems of fluoroquinolones - A review.

J Control Release

Department of Biomaterials Chemistry, Chair of Analytical Chemistry and Biomaterials, Faculty of Pharmacy With the Laboratory Medicine Division, Medical University of Warsaw, 1 Banacha St., Warsaw 02-097, Poland. Electronic address:

Published: January 2019

Recently, growing interest in polymers (natural and synthetic) as drug carriers in controlled release formulations and drug targeting systems that may improve the efficacy of treatment and reduce the side effects of a drug therapy, has been observed. Special attention has been paid to improving the effectiveness of antibiotics, which constitute a very important, often life-saving group of drugs. In this paper, we review polymers as macromolecular carriers of fluoroquinolones, a group of antibiotics with a broad spectrum of activity. We consider both physical intermixtures and chemical conjugates, although we discuss in greater depth the latter type of coupling, in which covalent bonds between drug molecules and polymers occur.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2018.12.021DOI Listing

Publication Analysis

Top Keywords

current state
4
state polymeric
4
polymeric delivery
4
delivery systems
4
systems fluoroquinolones
4
fluoroquinolones review
4
review growing
4
growing interest
4
interest polymers
4
polymers natural
4

Similar Publications

Prenatal stress has a well-established link to negative biobehavioral outcomes in young children, particularly for girls, but the specific timing during gestation of these associations remains unknown. In the current study, we examined differential effects of timing of prenatal stress on two infant biobehavioral outcomes [i.e.

View Article and Find Full Text PDF

The rise in popularity of two-photon polymerization (TPP) as an additive manufacturing technique has impacted many areas of science and engineering, particularly those related to biomedical applications. Compared with other fabrication methods used for biomedical applications, TPP offers 3D, nanometer-scale fabrication dexterity (free-form). Moreover, the existence of turnkey commercial systems has increased accessibility.

View Article and Find Full Text PDF

Enhancing the ferroelectric performance of HfZrOfilms by optimizing the incorporation of Al dopant.

Nanotechnology

January 2025

School of Electrical Engineering, State Key Laboratory of Electrical Insulation and Power Equipment, Xi'an Jiaotong University, Xianning West Road No.28 Xi'an Shannxi Province, Xi'an, Shaanxi, 710049, CHINA.

HfO-based ferroelectric (FE) thin films have gained considerable interest for memory applications due to their excellent properties. However, HfO₂-based FE films face significant reliability challenges, especially the wake-up and fatigue effects, which hinder their practical application. In this work, we fabricated 13.

View Article and Find Full Text PDF

Rehabilomics Strategies Enabled by Cloud-Based Rehabilitation: Scoping Review.

J Med Internet Res

January 2025

Department of Physical Medicine and Rehabilitation, Korea University Anam Hospital, Seoul, Republic of Korea.

Background: Rehabilomics, or the integration of rehabilitation with genomics, proteomics, metabolomics, and other "-omics" fields, aims to promote personalized approaches to rehabilitation care. Cloud-based rehabilitation offers streamlined patient data management and sharing and could potentially play a significant role in advancing rehabilomics research. This study explored the current status and potential benefits of implementing rehabilomics strategies through cloud-based rehabilitation.

View Article and Find Full Text PDF

Interferon-gamma (IFN-γ) is an important cytokine associated with antitumor immunity and has been implicated in the pathogenesis and progression of lung cancer. Nevertheless, no bibliometric analyses have been published in this field to date, and thus we aim to address this gap in knowledge. A search of the Web of Science (WOS) for literature related to the treatment of lung cancer with IFN-γ was conducted from 2002 to 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!